Citations 1
P1030: SPLEEN VOLUME REDUCTION PREDICTS SURVIVAL IN MYELOFIBROSIS PATIENTS ON PACRITINIB BUT NOT BEST AVAILABLE THERAPY: PERSIST-2 LANDMARK OVERALL SURVIVAL ANALYSIS
Ajufo, Helen, Harrison, Claire , Palmer, Jeanne , Derkach, Andrii, Roman‐Torres, Karisse, Buckley, Sarah , Rampal, Raajit K. , Bewersdorf, Jan Philipp , Palandri, Francesca , Mascarenhas, John , Gerds, Aaron T. , Kiladjian, Jean‐Jacques , Дмитрович, Деркач Андрій
HemaSphere | August 22, 2023 | Volume: 7 | Issue: S3 | Pages: e44640da
